NeoGenomics CEO Anthony Zook acknowledged the company's revenue miss on August 12, 2025.
2 reports, 2 independent
Updated Aug 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeoGenomics CEO Anthony Zook acknowledged the company's revenue miss on August 12, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
Coverage
Newest first; wire copies grouped- StockStoryNEO Q2 Deep Dive: Guidance Reset Amid Pharma Weakness, Delayed Product Launches Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q2 CY
- The News-PressFort Myers-based NeoGenomics sees stock plunge after reporting mixed results for Q2 NeoGenomics reported mixed results for the second quarter. The Fort Myers-based cancer testing and research lab ann